Branstetter Joshua W, Barker Leanna, Yarbrough April, Ross Shannon, Stultz Jeremy S
J Pediatr Pharmacol Ther. 2021;26(7):659-668. doi: 10.5863/1551-6776-26.7.659. Epub 2021 Sep 24.
The goals of antimicrobial stewardship programs (ASPs) are to optimize antimicrobial prescribing habits in order to improve patient outcomes, reduce antimicrobial resistance, and reduce hospital costs. Multiple society-endorsed guidelines and government policies reinforce the importance of ASP implementation. Effective antimicrobial stewardship can impact unique patients, hospitals, and societal antibiotic-resistance burden. The role and subsequent success of these programs has largely been reported in the adult population. Pediatric and neonatal intensive care units present unique challenges for traditional antimicrobial stewardship approaches. The purpose of this review article is to explore the challenges of appropriate antibiotic use in the pediatric and neonatal intensive care units and to summarize strategies ASPs can use to overcome these challenges. These problems include non-specific disease presentations, limited evidence for definitive treatment durations in many pediatric infections, fewer pediatric-trained infectious disease physicians, and applicability of intensive laboratory obtainment, collection, and interpretation. Additionally, many ASP implementation studies evaluating the efficacy of ASPs exclude the PICU and NICU. Areas of focus for pediatric ASPs should likely include appropriate antibiotic initiation, appropriate antibiotic duration, and appropriate antibiotic de-escalation.
抗菌药物管理计划(ASPs)的目标是优化抗菌药物的处方习惯,以改善患者预后、减少抗菌药物耐药性并降低医院成本。多个得到社会认可的指南和政府政策都强调了实施抗菌药物管理计划的重要性。有效的抗菌药物管理能够对个体患者、医院以及全社会的抗生素耐药负担产生影响。这些计划的作用及后续成效在很大程度上已在成年人群体中得到报道。儿科和新生儿重症监护病房对于传统的抗菌药物管理方法而言存在独特的挑战。这篇综述文章的目的是探讨儿科和新生儿重症监护病房合理使用抗生素所面临的挑战,并总结抗菌药物管理计划可用于克服这些挑战的策略。这些问题包括非特异性的疾病表现、许多儿科感染中确定治疗疗程的证据有限、受过儿科培训的感染病医生较少,以及强化实验室检查的获取、采集和解读的适用性。此外,许多评估抗菌药物管理计划效果的实施研究都将儿科重症监护病房和新生儿重症监护病房排除在外。儿科抗菌药物管理计划的重点领域可能应包括合理的抗生素起始使用、合理的抗生素疗程以及合理的抗生素降阶梯使用。